glp 1 novo Ro Launches Wegovy® Pill Through Integration with Nordisk Novo Nordisk Sues Eli Lilly

Eur J Heart Fail 19(12):15741585 Balestrieri G, Limonta R, Ponti E, Merlo A, Sciatti E, DIsa S et al (2024) The therapy and management of heart failure with preserved ejection fraction: new insights on treatment

References Bray GAPJ

Noura Abul-Husn, MD, PhD , Chief Medical Officer at the 23andMe Research Institute

The present review provides (1) an overview in the pathophysiology of NAFLD, including the potential involvement of GLP-1 and glucagon, (2) an introduction to the currently available GLP-1RAs and (3) outlines the potential of emerging GLP-1RAs and GLP-1/glucagon receptor co-agonists in the treatment of NAFLD

If youre weighing the risks and benefits of GLP-1 and pregnancy, postpartum use, or fertility support, or just need a safe space to talk through your options, I invite you to book a free Clarity Call